Strbe et al., 2021), intratracheal alcohol instillation (Stancic-Rokotov et al., 2001a
Target: 5 mg once daily or 2.5 mg twice daily (BID)
Identification of a mutation that relieves gamma-glutamyl kinase from allosteric feedback inhibition by proline
Alternatively, null results across trials might indicate that current supplementation strategies are inadequate to achieve cardiovascular benefits, either due to insufficient dosing, inappropriate target populations, or suboptimal timing of the intervention
Pinch skin fold and insert needle at 4590
2023, Feb;24(2):34958 Appelman B, Charlton BT, Goulding RP, Kerkhoff TJ, Breedveld EA, Noort W, et al